Lixte Biotechnology Holdings Inc LIXT Q4 2024 Earnings Net Loss of 027 Per Share as Pipeline Progress Continues DFTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Reports WiderThanExpected Loss COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains MDWD Q4 2025 Earnings Narrower Loss Beats Estimates as Operational Focus Continues XPON Q2 2025 Earnings Strong EPS Beat Highlights Cost Discipline Liquidia Corporation LQDA Gains 32 as Biotech Momentum Builds Key Levels Ahead Advance Auto Parts AAP Rebounds Stock Rises 276 Eyes Resistance Allegro MicroSystems ALGM Surges 28 as Bulls Test Key Resistance at 4825 A10 Networks ATEN Surges 395 Breaking Above Key Resistance Levels Senmiao Technology AIHS Q1 2026 Earnings Narrowed Loss Amid Operational Restructuring